FibroBiologics Inc. Common Stock
FBLG | NASDAQ
$1.39
+$0.03 (+2.21%)
Sep 22, 2026, 2:15 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | 234K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | -234K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -4.03M | -5.07M | -2.59M | -5.04M | -4.49M | -4.53M | -3.71M | -3.35M | -3.22M | -3.45M | -2.48M | -2.05M | -2.09M | -2.27M | -1.3M | -1.34M | -911K | -911K |
Interest Income | 15K | 20K | 25K | 73K | 50K | 99K | 63K | 79K | 70K | 39K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -4.12M | -5M | -3.24M | -5.78M | -4.66M | -4.97M | -3.1M | -500K | 898K | -8.46M | -9.72M | -2.19M | -2.16M | -2.42M | -1.52M | -1.56M | -1.02M | -1.02M |
Net Income | -4.12M | -5M | -3.24M | -5.78M | -4.66M | -4.97M | -3.1M | -500K | 898K | -8.46M | -9.72M | -2.19M | -2.16M | -2.42M | -1.52M | -1.56M | -1.02M | -1.02M |
Selling & General & Admin | 2.38M | 2.12M | 1.79M | 2.25M | 2.45M | 2.75M | 2.36M | 2.14M | 2.25M | 2.49M | 1.71M | 1.48M | 1.55M | 1.79M | 959K | 993K | 684K | 684K |
Research & Development | 1.66M | 2.95M | 797K | 2.79M | 2.04M | 1.78M | 1.36M | 1.21M | 975K | 960K | 773K | 571K | 547K | 478K | 345K | 348K | 227K | 227K |
Other Expenses | n/a | n/a | -234K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 4.03M | 5.07M | 2.36M | 5.04M | 4.49M | 4.53M | 3.71M | 3.35M | 3.22M | 3.45M | 2.48M | 2.05M | 2.09M | 2.27M | 1.3M | 1.34M | 911K | 911K |
Interest Expense | -7K | 4K | 204K | n/a | n/a | n/a | 6K | 5K | 5K | 4K | 1K | n/a | 10K | 135K | 220K | 221K | 106.5K | 106.5K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 5.07M | 2.59M | 5.04M | 4.49M | 4.53M | 3.71M | 3.35M | 3.22M | 3.45M | 2.48M | 2.05M | 2.09M | 2.27M | 1.3M | 1.34M | 911K | 911K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 6.27M | 2.23M | 2.23M | 2.15M | 1.93M | 1.83M | 1.74M | 1.68M | 1.64M | 1.56M | 1.59M | 1.62M | 1.62M | 1.62M | 1.52M | 1.52M | 1.41M | 1.41M |
Shares Outstanding (Diluted) | 6.27M | 2.23M | 2.23M | 2.15M | 1.93M | 1.83M | 1.74M | 1.68M | 1.64M | 1.56M | 1.59M | 1.62M | 1.62M | 1.62M | 1.52M | 1.52M | 1.41M | 1.41M |
EPS (Basic) | -0.66 | -2.24 | -0.98 | -2.60 | -2.40 | -2.80 | -1.78 | -0.20 | 0.60 | -5.40 | -6.20 | -1.35 | -1.33 | -3 | -1 | -1.03 | -0.72 | -0.72 |
EPS (Diluted) | -0.66 | -2.24 | -0.98 | -2.60 | -2.40 | -2.80 | -1.78 | -0.20 | 0.60 | -5.40 | -6.20 | -1.35 | -1.33 | -3 | -1 | -1.03 | -0.72 | -0.72 |
EBITDA | -4.03M | -4.76M | -2.81M | -5.55M | -4.45M | -4.81M | -2.94M | -352K | 1.04M | -8.32M | -9.59M | -2.08M | -2.05M | -2.18M | -1.21M | -1.34M | n/a | n/a |
EBIT | n/a | -5M | -3.04M | -5.78M | -4.66M | -4.97M | -3.09M | -495K | 903K | -8.46M | -9.72M | -2.19M | -2.15M | -2.28M | -1.3M | -1.34M | -911K | -911K |
Depreciation & Amortization | n/a | 237K | 234K | 231K | 206K | 161K | 153K | 143K | 140K | 137K | 130K | 112K | 99K | 96K | 94K | 136 | 911K | 911K |
Add to Watchlist
Select watchlists to add or remove FBLG